Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Medplus Health Services informed exchanges that its subsidiary Optival Health Solutions Private Limited received a suspension order for the Drug License of a store located in Lingaraj Nagar, Karnataka. The order was issued by the Assistant Director, Drugs Control Administration, Hubli Circle, under Rule 65 of the Drugs and Cosmetics Act, 1940, and was received on March 16, 2026. The license has been suspended for five days. The company estimates a potential revenue loss of Rs 1.77 lakhs due to this action.
The financial impact is negligible at just Rs 1.77 lakhs, and only a single store out of Medplus's large retail network is affected, so this is unlikely to have any meaningful effect on the stock price or shareholder value.